Here are the 424B prospectus supplements from Klotho Neurosciences, Inc. (KLTO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow KLTO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KLTO filings page.
Klotho Neurosciences, Inc. registers up to 75,103,879 shares of Common Stock for resale by selling stockholders under a Form S-3 shelf prospectus supplement dated February 24, 2026. The prospectus also registers resale of shares to be issued in a private placement the company expects to close on or about March 15, 2026, under which the company expects to sell an aggregate of 34,551,939 shares and warrants exercisable for up to 34,551,939 shares.
The registration covers (1) resale by identified selling stockholders of existing shares and shares issuable on exercise of existing warrants and (2) resale of shares and shares issuable upon exercise of warrants to be issued in the private placement. The company will not receive proceeds from sales by the selling stockholders, but will receive proceeds if warrants are exercised.